Apple: An Unexpected Positive Appears

Apple: An Unexpected Positive Appears By Paulo Santos • 49 comments AT&T: Wow That Was Timely By Christopher F. Davis • 15 comments My Top Pick For 2017 By Ian Bezek • 63 comments PRO Pick of the Day My Top Pick For 2017 By Ian Bezek • 31 comments PRO ideas are forward-looking, under-the-radar opportunities from top authors. Ian Bezek lays out his top pick for 2017 - Grupo Aeroportuario del Pacifico, a 5% dividend yielder sold off due to Trump fears. Learn more about SA Pro Editors' Picks Alphabet Just Beginning To Monetize Its Ventures While Trading At A Discount By Midas Investor ConocoPhillips In 2017: The Eagle Ford Shale Makes A Big Comeback By Michael Fitzsimmons A Focus On The Old Energy Trusts Like Hugoton, Mesa, And San Juan Basin By Dividend Master Why The SEC May Come A Knockin' On Allergan's Non-GAAP Door By Seven Corners Capital Management Could TransDigm Be The Valeant Of The Aerospace Industry? By Citron Research More Editors' Picks» Long Ideas Implications Of The Latest Smash In Bristol-Myers Squibb Stock by DoctoRx Apple: Renewing Mac Focus In The New Year by Mark Hibben Tesla: The Gigafactory Is The Key by Garrett Brusewitz Chesapeake Energy Buys Back Preferred Shares Signaling BUY! by Giovanni DiMauro Ford Is A Large Company With A Small Price by Antonio Carradinha More Long Ideas» Short Ideas BlackBerry: Be Anxious For Nothing In 2017 by Kayode Omotosho Did Martin Shkreli Kill Mallinckrodt's Business Model? by Shock Exchange Chipotle Is On The Road To $250 by Hedgeye My Netflix Annual Update: The Stock Is Up 50% And Clearly Overvalued by Chad Brand Zumiez: An Apparel Stock You Need To Avoid by Investonomics More Short Ideas» Quick Picks & Lists Why AT&T's Streaming Troubles May Just Be Beginning by The Entertainment Oracle DryShips Stock: The Worst Dollar You'll Ever Spend by Austin Craig ConocoPhillips Has To Get There First by Long Player 10 Value Stocks In This Uncertain Trump Market by Matt Hogan Upcoming Events: Copaxone Patent Decision And Catabasis Muscular Dystrophy Bid by EP Vantage More Quick Picks & Lists» IPO Analysis Medtechs Flock To London As 2016 Sees Biggest IPO Ever by EP Vantage U.S. IPO Week Ahead: AppDynamics Headlines Rush Of 8 IPOs by Renaissance Capital IPO Research U.S. IPO Weekly Recap: FRAC Pops 14% In First IPO Of 2017, And 10 Others Launch by Renaissance Capital IPO Research More IPO Analysis» Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio. Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha. Unsubscribe from this email or manage all your Seeking Alpha email choices here. To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders. Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017